Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Geoffrey R. Connors MD, FACP Associate Editor

Virginia A. Brady MD Associate Editor

See All Experts

featured

Published in Respiratory Medicine and

Journal Scan / Research · January 04, 2023

Intermediate- vs Low-Dose LMWH in Pregnant and Postpartum Women With a History of VTE

The Lancet

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Saskia Middeldorp MD

The Lancet

Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial

Lancet 2022 Oct 28;[EPub Ahead of Print], IM Bistervels, A Buchmüller, HMG Wiegers, F Ní Áinle, B Tardy, J Donnelly, P Verhamme, AF Jacobsen, AT Hansen, MA Rodger, MT DeSancho, RG Shmakov, N van Es, MH Prins, C Chauleur, S Middeldorp

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Intermediate- vs Low-Dose LMWH in Pregnant and Postpartum Women With a History of VTE

Additional Info

Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial

Further Reading

Economic Value of Improving Sensitivity Bronchoscopy for Malignancy Diagnosis in Peripheral Pulmonary Lesions

Biomarker-Guided Antibiotic Duration in Patients Hospitalized With Suspected Sepsis

High-Flow Nasal Oxygen vs Noninvasive Ventilation in Patients With Acute Respiratory Failure

Global, Regional, and National Mortality Burden Attributable to Air Pollution From Landscape Fires

Benralizumab in the Treatment of Patients With Eosinophilic Exacerbations of Asthma and COPD

Efficacy and Safety of Adjunctive Midodrine Therapy for Vasopressor-Dependent Shock in the ICU

Prevalence of Chronic Airflow Limitation, Emphysema, and Impaired Diffusing Capacity in Relation to Smoking Habits in Middle-Aged Populations

Feasibility of Antibiotic Allergy De-Labeling in the ICU

Impact of Dyspnea on Quality of Life in Adults With Respiratory Symptoms Without a Defined Diagnosis

2024 Top Story in Respiratory Medicine: Dupilumab in COPD

2024 Top Story in Respiratory Medicine: Effect of Metagenomic Sequencing on Clinical Outcomes of Patients With Severe Community-Acquired Pneumonia

Recently Updated